| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | calcium carbonate/colecalciferol (Kalcipos-D®) |
| Formulation | 500 mg/ 800 units chewable tablet; 500 mg/ 800 units film-coated tablet |
| Reference number | 1444 |
| Indication | Prevention and treatment of calcium and vitamin D deficiency in the elderly. Vitamin D and calcium supplement in addition to specific osteoporosis treatment of patients who are at risk of vitamin D and calcium deficiency |
| Company | Meda Pharmaceuticals Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/10/2011 |